Form 4: Pacific Biosciences Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Van Oene, Chief Operating Officer of Pacific Biosciences, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 3, 2025, Mark Van Oene, the Chief Operating Officer of Pacific Biosciences, sold 6,486 shares of common stock at a weighted average price ranging from $1.39 to $1.46 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Van Oene beneficially owns 1,497,695 shares, which includes 7,500 shares purchased under the company's 2010 Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock sale for tax purposes, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are a routine part of the US stock market, and are required by the SEC to ensure transparency of trading by corporate insiders.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the stock sale and purchase under the Employee Stock Purchase Plan. |
| 03/05/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.